{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:19:45Z","timestamp":1790943585668,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.antiviral.2011.01.010","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T04:33:05Z","timestamp":1297225985000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus"],"prefix":"10.1016","volume":"90","author":[{"given":"Sarah A.","family":"Goodchild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn M.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa R.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"Lanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo V.","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Phillpotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.01.010_bib0005","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jmb.2007.02.100","article-title":"Analyzing the \u201cdegree of humanness\u201d of antibody sequences","volume":"369","author":"Abhinandan","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1006\/viro.1995.1197","article-title":"Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse","volume":"208","author":"Charles","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0167-5699(83)90013-0","article-title":"Advantages of rat monoclonal antibodies","volume":"4","author":"Clark","year":"1983","journal-title":"Immunol. Today"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/mabs.1.2.7909","article-title":"Immunotoxicity of monoclonal antibodies","volume":"1","author":"Descotes","year":"2009","journal-title":"mAbs"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S0022172400041851","article-title":"A mobile form of the Henderson apparatus","volume":"67","author":"Druett","year":"1969","journal-title":"J. Hyg. Camb."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-2836(92)91010-M","article-title":"Antibody framework residues affecting the conformation of the hypervariable loops","volume":"224","author":"Foote","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.micro.55.1.235","article-title":"Biological weapons \u2013 a primer for microbiologists","volume":"55","author":"Hawley","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0055","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/S0264-410X(02)00300-6","article-title":"Overview: cause and prevention in biowarfare and bioterrorism","volume":"20","author":"Hilleman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0060","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.vaccine.2007.01.034","article-title":"Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virus","volume":"25","author":"Hu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0065","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/j.vaccine.2010.06.038","article-title":"A recombinant humanised monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus","volume":"28","author":"Hu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0070","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.81925-0","article-title":"A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus","volume":"87","author":"Hunt","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0075","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1371\/journal.pntd.0000739","article-title":"The first human epitope map of the Alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutalizing activity","volume":"13","author":"Hunt","year":"2010","journal-title":"PLoS Neglect Trop. Dis."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0042-6822(90)90137-G","article-title":"Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide","volume":"179","author":"Hunt","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2005.01.001","article-title":"Immunogenicity of engineered antibodies","volume":"36","author":"Hwang","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0090","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/321522a0","article-title":"Replacing the complementarity-determining regions in a human antibody with those from a mouse","volume":"321","author":"Jones","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0095","series-title":"Sequences of Proteins of Immunological Interest","author":"Kabat","year":"1991"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1472-6750-8-66","article-title":"Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)","volume":"8","author":"Kirsch","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2144\/97233st09","article-title":"Analysis of assembly of synthetic antibody fragments: expression of functional scFv with predefined specificity","volume":"23","author":"Kobayashi","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0110","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.molimm.2006.09.029","article-title":"A molecular immunology approach to antibody humanization and functional optimization","volume":"44","author":"Lazar","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0115","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/jvi.55.3.594-600.1985","article-title":"Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encepalomyelitis virus infection with glycoprotein-specific monoclonal antibodies","volume":"55","author":"Mathews","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0021-8502(73)90006-2","article-title":"The Collison nebulizer: description, performance and application","volume":"4","author":"May","year":"1973","journal-title":"Aerosol. Sci."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2006.11.007","article-title":"Inhibition of multiple strains of Venuzuelan equine encephalitis virus by a pool of four short interferening RNAs","volume":"75","author":"O\u2019Brien","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1743-422X-6-206","article-title":"Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains","volume":"6","author":"O\u2019Brien","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0135","first-page":"33","article-title":"The estimation of the dispersion of windborne material","volume":"90","author":"Pasquill","year":"1961","journal-title":"Meteorol. Mag."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0140","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2008.03.032","article-title":"Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers","volume":"376","author":"Paessler","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virusres.2006.02.003","article-title":"Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III","volume":"120","author":"Phillpotts","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0155","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Phillpotts","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0160","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.vaccine.2004.06.056","article-title":"Intranasal immunisation with defective Adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus","volume":"23","author":"Phillpotts","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/bsp.2009.0032","article-title":"Alphavirus antiviral drug development: scientific gap analysis and prospective research areas","volume":"7","author":"Reichert","year":"2009","journal-title":"Biosecur. Bioterror."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.1988.38.187","article-title":"Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus","volume":"38","author":"Rico-Hesse","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1086\/513978","article-title":"Epidemic Venezuelan equine encephalitis in La Guajira Colombia, 1995","volume":"175","author":"Rivas","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0180","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/jcm.35.7.1887-1890.1997","article-title":"Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype I Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay","volume":"35","author":"Roehrig","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0042-6822(82)90346-4","article-title":"Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies","volume":"118","author":"Roehrig","year":"1982","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0042-6822(88)90659-9","article-title":"In vitro mechanisms of monoclonal antibody neutralization of alphaviruses","volume":"165","author":"Roehrig","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"Roehrig","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0200","first-page":"879","article-title":"Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy","volume":"45","author":"Schroff","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1359-6446(05)03638-X","article-title":"Elimination mechanisms of therapeutic monoclonal antibodies","volume":"11","author":"Tabrizi","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2011.01.010_bib0215","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2174\/0929867023368647","article-title":"Rationally engineered proteins or antibodies with absent or reduced immunogenicity","volume":"9","author":"Tangri","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0220","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.4049\/jimmunol.174.6.3187","article-title":"Rationally engineered therapeutic proteins with reduced immunogenicity","volume":"174","author":"Tangri","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0230","first-page":"164","article-title":"Venezuelan equine encephalitis in BALB\/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation","volume":"120","author":"Vogel","year":"1996","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0235","first-page":"227","article-title":"Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus","volume":"137","author":"Walton","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4269\/ajtmh.2001.65.64","article-title":"Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains","volume":"65","author":"Wang","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2011.01.010_bib0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Ann. Rev. Entomol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:32:24Z","timestamp":1762252344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0166354211000283"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.01.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2011 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}